Page last updated: 2024-08-24

tepoxalin and Bone Cancer

tepoxalin has been researched along with Bone Cancer in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dow, SW; Gustafson, DL; Hansen, RJ; Sottnik, JL; Thamm, DH	1
Bushey, JJ; Goupil, RC; Peters-Kennedy, J; Wakshlag, JJ	1

Other Studies

2 other study(ies) available for tepoxalin and Bone Cancer

Article	Year
Induction of VEGF by tepoxalin does not lead to increased tumour growth in a canine osteosarcoma xenograft. Veterinary and comparative oncology, 2011, Volume: 9, Issue:2 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Bone Neoplasms; Cell Proliferation; Dog Diseases; Dogs; Hypoxia-Inducible Factor 1, alpha Subunit; In Vitro Techniques; Male; Mice; Osteosarcoma; Pyrazoles; Transplantation, Heterologous; Tumor Burden; Vascular Endothelial Growth Factors	2011
Prevalence of 5-lipoxygenase expression in canine osteosarcoma and the effects of a dual 5-lipoxygenase/cyclooxygenase inhibitor on osteosarcoma cells in vitro and in vivo. Veterinary pathology, 2012, Volume: 49, Issue:5 Topics: Animals; Arachidonate 5-Lipoxygenase; Bone Neoplasms; Cell Proliferation; Cell Survival; Cyclooxygenase Inhibitors; Dog Diseases; Dogs; Female; Immunohistochemistry; Lipoxygenase Inhibitors; Male; Mice; Mice, Nude; Osteosarcoma; Pyrazoles; Retrospective Studies; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2012

Article

Year

Induction of VEGF by tepoxalin does not lead to increased tumour growth in a canine osteosarcoma xenograft.

Veterinary and comparative oncology, 2011, Volume: 9, Issue:2

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Bone Neoplasms; Cell Proliferation; Dog Diseases; Dogs; Hypoxia-Inducible Factor 1, alpha Subunit; In Vitro Techniques; Male; Mice; Osteosarcoma; Pyrazoles; Transplantation, Heterologous; Tumor Burden; Vascular Endothelial Growth Factors

2011

Prevalence of 5-lipoxygenase expression in canine osteosarcoma and the effects of a dual 5-lipoxygenase/cyclooxygenase inhibitor on osteosarcoma cells in vitro and in vivo.

Veterinary pathology, 2012, Volume: 49, Issue:5

Topics: Animals; Arachidonate 5-Lipoxygenase; Bone Neoplasms; Cell Proliferation; Cell Survival; Cyclooxygenase Inhibitors; Dog Diseases; Dogs; Female; Immunohistochemistry; Lipoxygenase Inhibitors; Male; Mice; Mice, Nude; Osteosarcoma; Pyrazoles; Retrospective Studies; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2012